Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Clptm1 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Clptm1 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLPTM1 mRNA | CTD | PMID:22206623 | Clptm1 | Rat | 14-Deoxy-11,12-didehydroandrographolide | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | 14-deoxy-11,12-didehydroandrographolide results in decreased expression of CLPTM1 mRNA | CTD | PMID:22101062 | Clptm1 | Rat | 17beta-estradiol | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of CLPTM1 mRNA | CTD | PMID:16705744 | Clptm1 | Rat | 17beta-estradiol | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of CLPTM1 mRNA | CTD | PMID:19167446 | Clptm1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Clptm1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CLPTM1 mRNA | CTD | PMID:21570461 | Clptm1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CLPTM1 mRNA | CTD | PMID:33387578 | Clptm1 | Rat | 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of CLPTM1 mRNA | CTD | PMID:21346803 | Clptm1 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CLPTM1 mRNA | CTD | PMID:20188158 | Clptm1 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Clptm1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of CLPTM1 protein | CTD | PMID:34186270 | Clptm1 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Clptm1 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of CLPTM1 mRNA | CTD | PMID:39298647 | Clptm1 | Rat | acrolein | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | Clptm1 | Rat | aflatoxin B1 | decreases methylation | ISO | CLPTM1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CLPTM1 gene | CTD | PMID:27153756 | Clptm1 | Rat | Aflatoxin B2 alpha | decreases methylation | ISO | CLPTM1 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of CLPTM1 intron | CTD | PMID:30157460 | Clptm1 | Rat | alpha-pinene | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | Clptm1 | Rat | antimony(0) | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Antimony results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | aristolochic acid A | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of CLPTM1 mRNA | CTD | PMID:33212167 | Clptm1 | Rat | arsane | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Clptm1 | Rat | arsenic atom | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Clptm1 | Rat | benzo[a]pyrene | decreases expression | ISO | Clptm1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CLPTM1 mRNA | CTD | PMID:22228805 | Clptm1 | Rat | benzo[a]pyrene | affects methylation | ISO | CLPTM1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CLPTM1 intron | CTD | PMID:30157460 | Clptm1 | Rat | benzo[e]pyrene | affects methylation | ISO | CLPTM1 (Homo sapiens) | 6480464 | benzo(e)pyrene affects the methylation of CLPTM1 intron | CTD | PMID:30157460 | Clptm1 | Rat | beta-lapachone | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of CLPTM1 mRNA | CTD | PMID:38218311 | Clptm1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of CLPTM1 mRNA | CTD | PMID:33754040 | Clptm1 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CLPTM1 mRNA | CTD | PMID:25181051 | Clptm1 | Rat | bisphenol A | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CLPTM1 protein | CTD | PMID:37567409 | Clptm1 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Clptm1 | Rat | bisphenol A | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of CLPTM1 mRNA; bisphenol A results in increased expression more ... | CTD | PMID:29275510|PMID:34186270 | Clptm1 | Rat | bisphenol AF | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of CLPTM1 protein | CTD | PMID:34186270 | Clptm1 | Rat | Bisphenol B | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of CLPTM1 protein | CTD | PMID:34186270 | Clptm1 | Rat | bisphenol F | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of CLPTM1 protein | CTD | PMID:34186270 | Clptm1 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Clptm1 | Rat | bortezomib | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of CLPTM1 mRNA | CTD | PMID:20977926 | Clptm1 | Rat | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of CLPTM1 mRNA | CTD | PMID:19167457 | Clptm1 | Rat | chromium atom | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Chromium results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | clobetasol | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | Clobetasol results in increased expression of CLPTM1 mRNA | CTD | PMID:27462272 | Clptm1 | Rat | deoxynivalenol | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of CLPTM1 protein | CTD | PMID:39638853 | Clptm1 | Rat | dioxygen | multiple interactions | ISO | Clptm1 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of CLPTM1 mRNA | CTD | PMID:30529165 | Clptm1 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Antimony Potassium Tartrate results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | disodium selenite | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of CLPTM1 mRNA | CTD | PMID:18175754 | Clptm1 | Rat | doxorubicin | affects response to substance | ISO | CLPTM1 (Homo sapiens) | 6480464 | CLPTM1 mRNA affects the susceptibility to Doxorubicin | CTD | PMID:16243817 | Clptm1 | Rat | elemental selenium | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Selenium results in increased expression of CLPTM1 mRNA | CTD | PMID:19244175 | Clptm1 | Rat | ethanol | affects splicing | ISO | Clptm1 (Mus musculus) | 6480464 | Ethanol affects the splicing of CLPTM1 mRNA | CTD | PMID:30319688 | Clptm1 | Rat | fenthion | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | Fenthion results in increased expression of CLPTM1 mRNA | CTD | PMID:34813904 | Clptm1 | Rat | folic acid | multiple interactions | ISO | Clptm1 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLPTM1 mRNA | CTD | PMID:22206623 | Clptm1 | Rat | genistein | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Genistein results in decreased expression of CLPTM1 mRNA | CTD | PMID:16705744 | Clptm1 | Rat | ivermectin | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CLPTM1 protein | CTD | PMID:32959892 | Clptm1 | Rat | leflunomide | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of CLPTM1 mRNA | CTD | PMID:28988120 | Clptm1 | Rat | manganese atom | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Clptm1 | Rat | manganese(0) | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Clptm1 | Rat | manganese(II) chloride | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Clptm1 | Rat | mercury atom | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Mercury results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | mercury atom | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Mercury results in increased expression of CLPTM1 mRNA | CTD | PMID:16823088 | Clptm1 | Rat | mercury(0) | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Mercury results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | mercury(0) | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Mercury results in increased expression of CLPTM1 mRNA | CTD | PMID:16823088 | Clptm1 | Rat | methapyrilene | affects methylation | ISO | CLPTM1 (Homo sapiens) | 6480464 | Methapyrilene affects the methylation of CLPTM1 intron | CTD | PMID:30157460 | Clptm1 | Rat | methidathion | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | methidathion results in increased expression of CLPTM1 mRNA | CTD | PMID:34813904 | Clptm1 | Rat | methotrexate | affects response to substance | ISO | CLPTM1 (Homo sapiens) | 6480464 | CLPTM1 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 | Clptm1 | Rat | methotrexate | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of CLPTM1 mRNA | CTD | PMID:17400583 | Clptm1 | Rat | N-nitrosodimethylamine | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Dimethylnitrosamine results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | nickel dichloride | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | nickel chloride results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | ozone | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | Clptm1 | Rat | paracetamol | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CLPTM1 mRNA | CTD | PMID:22230336 | Clptm1 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CLPTM1 mRNA | CTD | PMID:33387578 | Clptm1 | Rat | perfluorooctanoic acid | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of CLPTM1 protein | CTD | PMID:26879310 | Clptm1 | Rat | potassium dichromate | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Potassium Dichromate results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | Clptm1 | Rat | rotenone | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Rotenone results in increased expression of CLPTM1 protein | CTD | PMID:39603559 | Clptm1 | Rat | selenium atom | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Selenium results in increased expression of CLPTM1 mRNA | CTD | PMID:19244175 | Clptm1 | Rat | sodium arsenite | multiple interactions | ISO | CLPTM1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Clptm1 | Rat | sodium arsenite | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CLPTM1 protein | CTD | PMID:38228842 | Clptm1 | Rat | sodium arsenite | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CLPTM1 mRNA | CTD | PMID:39719251 | Clptm1 | Rat | sulforaphane | multiple interactions | ISO | Clptm1 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of CLPTM1 mRNA | CTD | PMID:30529165 | Clptm1 | Rat | temozolomide | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of CLPTM1 mRNA | CTD | PMID:31758290 | Clptm1 | Rat | thiram | decreases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Thiram results in decreased expression of CLPTM1 mRNA | CTD | PMID:38568856 | Clptm1 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of CLPTM1 mRNA | CTD | PMID:33387578 | Clptm1 | Rat | triphenyl phosphate | affects expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CLPTM1 mRNA | CTD | PMID:37042841 | Clptm1 | Rat | triptonide | decreases expression | ISO | Clptm1 (Mus musculus) | 6480464 | triptonide results in decreased expression of CLPTM1 mRNA | CTD | PMID:33045310 | Clptm1 | Rat | urethane | increases expression | ISO | CLPTM1 (Homo sapiens) | 6480464 | Urethane results in increased expression of CLPTM1 mRNA | CTD | PMID:28818685 | Clptm1 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of CLPTM1 mRNA | CTD | PMID:23034163 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















